Information Provided By:
Fly News Breaks for May 3, 2018
TECH
May 3, 2018 | 08:21 EDT
Leerink analyst Puneet Souda raised his price target for Bio-Techne to $160 from $151 as he believes its consumables-heavy portfolio remains differentiated, contributing to above-industry growth and margins in his Life Science Tools coverage universe. The analyst reiterates an Outperform rating on the shares.